The molecular mechanisms underlying MHC downregulation in MPNST remain unclear, but data suggest that the transcriptional modulation of co-activators and chaperone proteins that regulate MHC expression may be involved [123]. The gene discussed is HLA-C; the disease is malignant peripheral nerve sheath tumor.